Past Medical History: --HTN --hyperlipidemia --DM Type 1 ([**First Name8 (NamePattern2) **] [**Last Name (un) **] notes): has had problems with hypoglycemia unawareness, last HgbA1C 10.8 in [**10-26**], missed last [**Last Name (un) **] appointment [**2128-3-4**] --CAD: [**11-21**] cath:LAD stent [**2-22**] cath: LAD stent with 95% instent restenosis, successful ptca [**10-22**]: cath LAD stent widely patent, 50% L cx lesion, RCA diffusely diseased to 60% Per Dr. [**Last Name (STitle) **] [**1-23**] discussion - will need to stay on plavix indefinitely.
Physical Exam: VS: 100.8, 133, 152/89, 30, 100% on 2L Gen: NAD, resting comfortably in bed, speaking on the phone HEENT: left eye prosthesis, right surgical pupil, EOMI, MM dry Neck: no JVD, no cervical lymphadenopathy Lungs: CTAB, good air movement CV: RRR, nl S1 and S2 Abd: +BS, S/NT/ND Ext: no c/c/e Neuro: A&Ox3, responding to questions appropriately, no confusion or agitation  Pertinent Results: [**2128-3-13**]  WBC-7.9 RBC-4.26 Hgb-12.3 Hct-36.6 MCV-86 MCH-28.9 MCHC-33.7 RDW-13.0 Plt Ct-248 [**2128-3-14**]  WBC-12.7*# RBC-4.06* Hgb-11.3* Hct-35.4* MCV-87 MCH-27.8 MCHC-31.9 RDW-12.8 Plt Ct-239 [**2128-3-15**]  WBC-12.0* RBC-3.76* Hgb-10.7* Hct-31.0* MCV-83 MCH-28.4 MCHC-34.4 RDW-13.3 Plt Ct-228 [**2128-3-15**]  WBC-9.7 RBC-4.11* Hgb-11.3* Hct-34.9* MCV-85 MCH-27.5 MCHC-32.3 RDW-13.0 Plt Ct-229 [**2128-3-16**]  WBC-7.6 RBC-3.86* Hgb-10.5* Hct-32.8* MCV-85 MCH-27.3 MCHC-32.2 RDW-13.0 Plt Ct-211 [**2128-3-17**]  WBC-6.0 RBC-4.10* Hgb-11.7* Hct-34.7* MCV-85 MCH-28.5 MCHC-33.7 RDW-12.9 Plt Ct-231  [**2128-3-13**] 11:00PM BLOOD PT-12.3 PTT-21.9* INR(PT)-1.0  [**2128-3-13**]  Glucose-596* UreaN-22* Creat-1.0 Na-137 K-5.1 Cl-100 HCO3-21* [**2128-3-14**]  Glucose-347* UreaN-15 Creat-0.7 Na-141 K-4.3 Cl-105 HCO3-23 [**2128-3-14**]  Glucose-150* UreaN-15 Creat-0.8 Na-144 K-3.5 Cl-112* HCO3-22 [**2128-3-15**]  Glucose-117* UreaN-15 Creat-0.7 Na-141 K-4.1 Cl-109* HCO3-23 [**2128-3-15**]  Glucose-240* UreaN-14 Creat-0.7 Na-139 K-4.3 Cl-106 HCO3-24 [**2128-3-16**]  Glucose-306* UreaN-16 Creat-0.7 Na-139 K-3.9 Cl-106 HCO3-24 [**2128-3-17**]  Glucose-198* UreaN-13 Creat-0.8 Na-141 K-3.7 Cl-105 HCO3-27 [**2128-3-13**] 11:00PM BLOOD ALT-37 AST-41* LD(LDH)-379* CK(CPK)-264* AlkPhos-163* Amylase-31 TotBili-0.5  [**2128-3-13**] 11:00PM  CK-MB-7 cTropnT-<0.01 [**2128-3-14**] 08:10AM  CK(CPK)-1034* BLOOD CK-MB-16* MB Indx-1.5 cTropnT-0.08* [**2128-3-14**] 03:58PM  CK(CPK)-1277* CK-MB-42* MB Indx-3.3 cTropnT-0.53* [**2128-3-14**] 10:07PM  CK(CPK)-1379* [**2128-3-15**] 04:20AM  CK-MB-46* MB Indx-3.5 cTropnT-1.42* [**2128-3-15**] 11:45AM  CK(CPK)-1157* BLOOD CK-MB-40* MB Indx-3.5 cTropnT-1.27* [**2128-3-15**] 08:54PM  CK(CPK)-994* cTropnT-0.88* [**2128-3-16**] 03:50AM  CK(CPK)-685* BLOOD CK-MB-17* MB Indx-2.5 cTropnT-0.80* [**2128-3-14**]  VitB12-789 Folate-19.8  [**2128-3-14**]  %HbA1c-10.8*  [**2128-3-14**]  Triglyc-99 HDL-63 CHOL/HD-2.5 LDLcalc-73 [**2128-3-13**]  Ammonia-62*  [**2128-3-13**] 11:00PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG  [**2128-3-14**] 10:35AM BLOOD Type-ART Temp-38.2 FiO2-100 pO2-186* pCO2-52* pH-7.12* calTCO2-18* Base XS--12 AADO2-495 REQ O2-81 Intubat-NOT INTUBA [**2128-3-14**] 11:02AM BLOOD Type-ART Temp-38.2 FiO2-100 pO2-337* pCO2-43 pH-7.21* calTCO2-18* Base XS--10 AADO2-353 REQ O2-62 Intubat-NOT INTUBA  CXR [**2128-3-15**]: In comparison with the study of [**3-14**], there is again moderate pulmonary edema with the heart normal in size.
Brief Hospital Course: 67F w/ DM1, HTN, hyperlipidemia, CAD with sudden onset of dysarthria and agitation on [**2128-3-13**], found to be in DKA in DKA with NSTEMI/Troponin leak and she was admitted to the MICU.
# DKA - it was felt that patient may have had an NSTEMI which led her to go into DKA (alternatively, she may have had an NSTEMI in the setting of DKA from poorly controlled sugars).
She was started on an insuling drip and transitioned to insuling sliding scale and lantus.
They changed her insulin regimen and decreased her lantus.
However, this was deferred when her mental status returned to baseline on treatment of blood sugars.
Meningitis was felt to be low probability and her meningitis antibiotics were stopped.
She was continued on levofloxacin for planned 7 day course.
She was started on a heparin drip on admission for medical management of NSTEMI which was continued for 48 hours.
She was continued on aspirin and plavix.
Her urine culture was pending at time of discharge, but her antibiotic course was extended to complete 7 days for UTI.
Medications on Admission: Plavix 75mg qd Toprol 25mg qd Imdur 30mg qd Lipitor 40mg qhs SL NTG prn lisinopril 20mg qd Lantus 24U qhs Humalog sliding scale ASA 325mg qd  Discharge Medications: 1.
Lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Aspirin 325 mg Tablet, Delayed Release (E.C.)
Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Atorvastatin 80 mg Tablet Sig: One (1) Tablet PO once a day.
Levofloxacin 500 mg Tablet Sig: One (1) Tablet PO once a day for 6 days.
Nitroglycerin 0.3 mg Tablet, Sublingual Sig: [**1-22**]  Sublingual prn as needed for chest pain: please call 911 or your primary care physician if you have chest pain.
Isosorbide Mononitrate 30 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).
Insulin Glargine 100 unit/mL Solution Sig: Sixteen (16) units Subcutaneous at bedtime.
Humalog 100 unit/mL Solution Sig: One (1)  Subcutaneous four times a day: as per your insulin sliding scale.
Toprol XL 25 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO once a day.
Discharge Disposition: Home  Discharge Diagnosis: NSTEMI DKA community acquired pneumonia  Secondary: DM1 (followed by [**Last Name (un) **], poorly controlled) HTN hyperlipidemia CAD TIA in [**2124**]   Discharge Condition: stable   Discharge Instructions: You were admitted to the hospital with slurred speech, high blood sugars.
Please call your primary care physician or seek immediate medical attention if you notice any of the following: chest pain/pressure, palpitations, dizziness, confusion, abdominal pain, weakness, fever, nausea/vomiting, chills, or slurred speech or any other concerning symptoms.
Medication changes: levofloxacin for 9 days total, last dose should be on [**2128-3-23**] Your insulin was adjusted during your hospital stay, your lantus was changed to 16 units once a day.
